Skip to main content
. Author manuscript; available in PMC: 2019 Jul 29.
Published in final edited form as: Urol Oncol. 2015 Mar 6;33(5):202.e1–202.e7. doi: 10.1016/j.urolonc.2015.01.023

Table 1.

Patient demographics for the initial and follow-up cohorts.

Patient Characteristic Initial Follow-Up

Number of men 152 58
Age, mean ± SD (range) 61.4 ± 7.1 years (40-79) 61.3 ± 7.02 years (45-77)
PSA, ng/mL, mean ± SD (range) 5.2 ± 3.2 ng/mL (0.2-23.3) 5.0 ± 3.1 ng/mL (0.2-20.0)
PSA density, mean ± SD (range) 0.09 ± 0.03 ng/mL2 (0.01-0.15) 0.09 ± 0.04 ng/mL2 (0.01-0.15)
Clinical stage
 T1c 152 58
Race (%)
 White 127 (83.6%) 51 (88%)
 African-American 21 (13.8%) 7 (12%)
 Other 4 (2.6%) 0

Prostate volume, mean ± SD (range) 58 ± 28 cm3 (23-161) 56 ± 25 cm3 (22-146)
Number of lesions, mean ± SD (range) 2.3 ± 1.2 (1-9) 2.3 ± 1.1 (1-5)
Highest suspicion score, (%)
 Low 32 (21.1%) 18 (31%)
 Moderate 109 (71.7%) 36 (62%)
 High 11 (7.2%) 4 (7%)

Abbreviations: PSA, prostate-specific antigen; SD, standard deviation.